nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acupuncture and integrative oncology for taxane-induced peripheral neuropathy: a randomized multicentered study
|
Ben-Arye, Eran |
|
|
33 |
5 |
p. 792-801 |
artikel |
2 |
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence
|
Plett, Helmut |
|
|
33 |
5 |
p. 734-740 |
artikel |
3 |
Aggressive angiomyxoma of the pelvis and vagina: a robotic and vaginal combined approach
|
Luzarraga Aznar, Ana |
|
|
33 |
5 |
p. 839-840 |
artikel |
4 |
Assessing gaps in motherhood after cancer: development and psychometric testing of the Survivorship Oncofertility Barriers Scale
|
Hoffman, Aubri |
|
|
33 |
5 |
p. 778-785 |
artikel |
5 |
Beyond post-operative readmissions: analysis of the impact of unplanned readmissions during primary treatment of advanced-stage epithelial ovarian cancer on long-term oncology outcome
|
Huang, Dandi |
|
|
33 |
5 |
p. 741-748 |
artikel |
6 |
Black and hispanic women have less support during cancer evaluation and treatment: results from a prospective patient reported outcomes program in gynecologic malignancy
|
Philp, Lauren |
|
|
33 |
5 |
p. 770-777 |
artikel |
7 |
Can the Tilburg Frailty Indicator predict post-operative quality of recovery in patients with gynecologic cancer? A prospective cohort study
|
Liu, Chunmei |
|
|
33 |
5 |
p. 761-769 |
artikel |
8 |
Can we improve survival with less overall morbidity for patients with intermediate-risk cervical cancer without the use of external beam radiotherapy?
|
Chargari, Cyrus |
|
|
33 |
5 |
p. 849-850 |
artikel |
9 |
Comparison of the Contracted Accordion, Expanded Accordion, and Clavien-Dindo complication grading scales after ovarian cancer cytoreduction
|
Mohammad, Arwa |
|
|
33 |
5 |
p. 727-733 |
artikel |
10 |
Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women
|
Snyman, Leon Cornelius |
|
|
33 |
5 |
p. 669-675 |
artikel |
11 |
Effect of BMI change on recurrence risk in patients with endometrial cancer
|
Laskov, Ido |
|
|
33 |
5 |
p. 713-718 |
artikel |
12 |
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*
|
Cibula, David |
|
|
33 |
5 |
p. 649-666 |
artikel |
13 |
ESGO/ESTRO/ESP updated guidelines in cervical cancer
|
Ramirez, Pedro T |
|
|
33 |
5 |
p. 667-668 |
artikel |
14 |
Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311)
|
Ishikawa, Mitsuya |
|
|
33 |
5 |
p. 692-700 |
artikel |
15 |
Ganglioglioma arising in an ovarian teratoma
|
Santoro, Angela |
|
|
33 |
5 |
p. 845-847 |
artikel |
16 |
Human chorionic gonadotropin expression in endometrial hyperplasia and endometrial carcinoma: could it be a new marker?
|
Daggez, Mine |
|
|
33 |
5 |
p. 707-712 |
artikel |
17 |
Hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: current evidence-based indications
|
Pareja, Rene |
|
|
33 |
5 |
p. 841-842 |
artikel |
18 |
Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers
|
Kim, Soyoun Rachel |
|
|
33 |
5 |
p. 755-760 |
artikel |
19 |
Improving Endometrial cancer assessment by combining the new techniqUe of GENomic profiling with surgical Extra uterIne disEase assessment (EUGENIE)
|
Kasius, Jenneke C |
|
|
33 |
5 |
p. 823-826 |
artikel |
20 |
Multi-institutional study on the role of post-operative radiotherapy in elderly patients with endometrial cancer
|
Yavas, Guler |
|
|
33 |
5 |
p. 719-726 |
artikel |
21 |
Opioid and benzodiazepine use in gynecologic oncology patients
|
Levytska, Khrystyna |
|
|
33 |
5 |
p. 786-791 |
artikel |
22 |
Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix
|
Peleg Hasson, Shira |
|
|
33 |
5 |
p. 683-691 |
artikel |
23 |
Ovarian clear cell carcinoma: an overview of key histopathologic features
|
Taylor, Haley |
|
|
33 |
5 |
p. 843-844 |
artikel |
24 |
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy
|
Chelariu-Raicu, Anca |
|
|
33 |
5 |
p. 812-822 |
artikel |
25 |
PET-MRI for evaluation of response to radiochemotherapy in patients with locally advanced cervical cancer
|
Weyl, Ariane |
|
|
33 |
5 |
p. 676-682 |
artikel |
26 |
Quality assurance in human papillomavirus testing for primary cervical screening
|
Cuschieri, Kate |
|
|
33 |
5 |
p. 802-811 |
artikel |
27 |
Rare presentation of endometrial cancer with uterine inversion
|
Hablase, Radwa |
|
|
33 |
5 |
p. 848 |
artikel |
28 |
Recurrent leiomyomatosis peritonealis disseminata
|
Sanchez Diaz, Emmanuel |
|
|
33 |
5 |
p. 827-832 |
artikel |
29 |
Secondary validation of an ovarian cancer-specific comorbidity index in a US population
|
Vranes, Chelsey |
|
|
33 |
5 |
p. 749-754 |
artikel |
30 |
The "06" committee: an untiring soldier in the Tunisian fight against gynecologic cancer
|
Ghalleb, Montassar |
|
|
33 |
5 |
p. 833-834 |
artikel |
31 |
The necessity to adhere to evidence-based indications for hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with ovarian cancer
|
Brennan, Donal J |
|
|
33 |
5 |
p. 851-852 |
artikel |
32 |
Transumbilical laparoendoscopic single-site radical trachelectomy with uterine arteries’ ascending branches preservation for early-stage cervical cancer
|
Chen, Yu |
|
|
33 |
5 |
p. 835-836 |
artikel |
33 |
Uterine smooth muscle tumors with uncertain malignant potential: analysis following fertility-saving procedures
|
Richtarova, Adela |
|
|
33 |
5 |
p. 701-706 |
artikel |
34 |
Visual dilation and curettage for the fertility-sparing treatment of atypical endometrial hyperplasia/endometrial intra-epithelial neoplasia: an easy to perform in-office technique
|
Casadio, Paolo |
|
|
33 |
5 |
p. 837-838 |
artikel |